Tag: CMS-3347-P

Key takeaways of the new proposed rule

On July 17 CMS announced a proposed rule that would delay Phase 3 requirements, including QAPI and ethics and compliance standards. These changes, fueled by the Trump administration, will modify previous rules set forth between October 2016 and June 2017. CMS-3347-P The first proposed rule, Medicare & Medicaid Programs; Requirements for Long-Term Care Facilities: Regulatory […]

Proposed rule includes change to antipsychotics regulation

CMS announced a new proposed rule (CMS-3347-P) this week, and among many changes, such as the delay of Phase 3 implementation, are changes to the use of antipsychotic medication. In the proposed rule, CMS states that “some nursing homes are circumventing the pressure to reduce antipsychotic drug use by seeking an appropriate diagnosis from a […]